Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Amortizatization of Intangibles (2016 - 2025)

Arrowhead Pharmaceuticals' Amortizatization of Intangibles history spans 15 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 78.7% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.3 million, down 83.98%, while the annual FY2025 figure was $5.8 million, 78.45% up from the prior year.
  • Amortizatization of Intangibles reached $1.2 million in Q4 2025 per ARWR's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $11.1 million in Q3 2024 to a low of -$7.0 million in Q2 2024.
  • Average Amortizatization of Intangibles over 5 years is $439350.0, with a median of $165500.0 recorded in 2021.
  • Peak YoY movement for Amortizatization of Intangibles: crashed 3401.96% in 2022, then skyrocketed 1027.66% in 2024.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $280000.0 in 2021, then plummeted by 346.43% to -$690000.0 in 2022, then surged by 221.01% to $835000.0 in 2023, then skyrocketed by 583.11% to $5.7 million in 2024, then plummeted by 78.7% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Amortizatization of Intangibles are $1.2 million (Q4 2025), $1.2 million (Q3 2025), and $1.8 million (Q2 2025).